The somatotopic organization of climbing fibers (CF) elicited by natural stimulation was determined for the intermediate zone of lobule V of Macaca fascicularis. In monkeys anesthetized with sodium pentobarbital, extracellular recordings of single Purkinje cells with CF responses were evaluated by gentle taps to the body and by computer-controlled punctate stimuli. Of the 311 Purkinje cells studied, 53% had CF responses elicited by cutaneous stimulation whereas the remaining cells were unresponsive. The entire ipsilateral, dorsal surface of the forelimb, face, and the oral cavity were represented in the intermediate zone. The topographic organization consisted of three 1.5–3 mm wide parasagittal bands of cells: a forelimb band medially, then a face band, and an unresponsive zone laterally. Most receptive fields in the forelimb band involved portions of the wrist, hand, and digits, although shoulder, arm, and forearm were also represented. The receptive fields of the hand usually included more than 1 digit and only a few fields contained the thumb. Most responses in the face band were elicited by stimulation of areas innervated by the mandibular division of the trigeminal nerve, although some responses were produced by stimulating areas related to the ophthalmic and maxillary divisions and to the anterior cutaneous nerve. Cells with similar receptive fields tended to be grouped together. The somatotopic CF organization of the monkey differed in many ways from the arrangement in the cat.

Keywords:
Cerebellum, Climbing fibers, Somatotopy, Spino-olivocerebellar pathways
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.